3-nitropropionic acid has been researched along with cystamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choo, YS; Lesort, M; Mao, Z | 1 |
| Calkins, MJ; Johnson, DA; Johnson, JA; Townsend, JA | 1 |
2 other study(ies) available for 3-nitropropionic acid and cystamine
| Article | Year |
|---|---|
Cystamine and cysteamine prevent 3-NP-induced mitochondrial depolarization of Huntington's disease knock-in striatal cells.
Topics: Animals; Cell Death; Cell Line; Clone Cells; Corpus Striatum; Cystamine; Cysteamine; Electron Transport Complex II; Glutathione; Huntingtin Protein; Membrane Potentials; Mice; Mice, Mutant Strains; Mitochondria; Mitochondrial Membranes; Mutation; Nerve Tissue Proteins; Nitro Compounds; Nuclear Proteins; Propionates | 2006 |
Cystamine protects from 3-nitropropionic acid lesioning via induction of nf-e2 related factor 2 mediated transcription.
Topics: Animals; Cells, Cultured; Cerebral Cortex; Cystamine; Dose-Response Relationship, Drug; Fluorescent Antibody Technique; Glutathione; Mice; Mice, Transgenic; Neuroglia; Neurons; Neuroprotective Agents; NF-E2-Related Factor 2; Nitro Compounds; Oxidative Stress; Propionates; Signal Transduction | 2010 |